Principal Financial Group’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-400,300
| Closed | -$1.54M | – | 2465 |
|
|
2022
Q4 | $1.54M | Sell |
400,300
-100
| -0% | -$384 | ﹤0.01% | 1807 |
|
|
2022
Q3 | $1.93M | Sell |
400,400
-5,702
| -1% | -$27.5K | ﹤0.01% | 1717 |
|
|
2022
Q2 | $3.23M | Buy |
406,102
+100,856
| +33% | +$802K | ﹤0.01% | 1693 |
|
|
2022
Q1 | $4.48M | Buy |
305,246
+2,012
| +0.7% | +$29.6K | ﹤0.01% | 1696 |
|
|
2021
Q4 | $6.13M | Buy |
303,234
+11,429
| +4% | +$231K | ﹤0.01% | 1597 |
|
|
2021
Q3 | $7.93M | Sell |
291,805
-3,358
| -1% | -$91.2K | 0.01% | 1512 |
|
|
2021
Q2 | $7.19M | Buy |
295,163
+75,664
| +34% | +$1.84M | ﹤0.01% | 1578 |
|
|
2021
Q1 | $5.36M | Buy |
219,499
+6,525
| +3% | +$159K | ﹤0.01% | 1647 |
|
|
2020
Q4 | $6.82M | Sell |
212,974
-1,406
| -0.7% | -$45K | 0.01% | 1441 |
|
|
2020
Q3 | $7.07M | Buy |
214,380
+61,293
| +40% | +$2.02M | 0.01% | 1285 |
|
|
2020
Q2 | $7.17M | Buy |
+153,087
| New | +$7.17M | 0.01% | 1247 |
|